Navigation Links
SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement
Date:11/5/2009

AUSTIN, Texas, Nov. 5 /PRNewswire/ -- SpineSmith Partners has signed an initial agreement with GenOsteo, Inc. to co-develop a unique scaffold that mimics the structure of natural cancellous bone. Following evaluation of several commercial products by SpineSmith's Research and Development Department, the company believes the GenOsteo scaffold represents a significant advancement in technology that creates a unique and ideal environment for the delivery of adult stem cells for skeletal repair and regeneration. Focused initially on developing fusion applications in conjunction with the use of SpineSmith interbody spinal spacers, SpineSmith believes that the proprietary GenOsteo process is unique and has the potential to provide an optimal cell carrier for several applications in spine, general orthopedics, trauma and plastic and reconstructive surgery.

Dr. James Poser, Vice President of Regenerative Medicine for SpineSmith, and his team will work closely with GenOsteo to bring this product to the market.

"GenOsteo has created an elegant and highly effective material that can be combined with adult stem cells for promoting bone formation. We look forward to collaborating with the scientists at GenOsteo to produce the next generation point-of-care adult stem cell product that will become the preferred fusion product of orthopedic and neurosurgeons," said Poser.

GenOsteo scientists developed the technology and have licensed the rights from the University of Texas at San Antonio. The GenOsteo process produces a calcium phosphate scaffold with uniform porosity, surface and resorption characteristics.

"GenOsteo is delighted to partner with SpineSmith to develop hydroxyapatite-based scaffold technology for optimal delivery of cell-based spinal implant therapies. It represents an ideal marriage of implant design, cell therapy and advanced material science," said Daniel Oh, president of GenOsteo and co-inventor of the technology.

Both companies will be attending the North American Spine Society (NASS) on November 11-14 in San Francisco. Members of the development team will be there to demonstrate and discuss how this unique scaffolding can revolutionize the presentation of cells in spinal fusion. SpineSmith and GenOsteo expect to bring this product to market in late 2010.

About GenOsteo

GenOsteo has developed a bone-like scaffold that is similar to the composition and structure of the inorganic portion of the natural cancellous bone. GenOsteo scaffolds allow the formation or regeneration of functional bone tissues and can be adapted to fit into implants such as with interbody spacers used in spinal fusion. In addition, bony defects resulting from trauma or disease in long bones can be regenerated to provide aesthetics as well as functional restoration by the use of the GenOsteo scaffolds.

About SpineSmith Partners, LP

SpineSmith Partners, LP is dedicated to creating better ways to facilitate and accelerate the healing of spinal disorders through integration of innovative medical devices and biologic technologies. SpineSmith designs, develops, and markets implants and biologics for surgical fixation, correction, and tissue regeneration of the spine. SpineSmith's dedication to a collaborative approach between scientists, engineers and spine surgeons results in the development of truly innovative biological and hardware technologies.

www.spinesmithusa.com

SOURCE SpineSmith Partners


'/>"/>
SOURCE SpineSmith Partners
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. SpineSmith Partners Collaborates with University of Texas Biomedical Engineering Students to Develop Innovative Products
2. Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health
3. Emerson Resources Forges Strategic Partnership with Bio Research
4. Public-Private Partnerships Key to Achieving Global Food Security, Says DuPont Leader
5. Diabetics: 3tailer Partners with MyGlucoHealth on World's 1st Blood Glucose Meter with Wireless Bluetooth for Diabetes
6. Professional Pricing Society Announces Educational Partnership with Vendavo -- "PPS Accepting Vendavo Pricing Knowledge Series Awards to Certified Pricing Professional Program"
7. SourceMedical's Therapy Software Partners with FOTO, the Leading Provider of Patient Outcome Surveys
8. Crescendo Biologics Raises GBP4.5 million in Seed-Funding Led by Sofinnova Partners
9. Blue Marble Energy and Bionavitas Announce Partnership to Produce Industrial Biochemicals from Microalgae
10. Northeast Indiana Regional Partnership to Participate in 2009 Orthopedic Design & Technology Conference & Exhibition
11. Abidance Consulting Partners with the FBI
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... International research firm Parks Associates announced today that Tom ... 2017 Annual Meeting , October 11 in Scottsdale, Arizona ... and how smart safety and security products impact the competitive landscape. ... Parks Associates: Smart Home Devices: Main Purchase Driver ... "The residential security market has experienced continued growth, and ...
(Date:10/9/2017)... , Oct. 9, 2017  BioTech Holdings announced ... by which its ProCell stem cell therapy prevents ... ischemia.  The Company, demonstrated that treatment with ProCell ... limbs saved as compared to standard bone marrow ... HGF resulted in reduction of therapeutic effect.  ...
(Date:10/9/2017)... Texas (PRWEB) , ... October ... ... study published on October 5, 2017, in the medical journal, Epilepsia, Brain ... with the gold standard, video EEG, in detecting generalized tonic-clonic seizures (GTCS) ...
(Date:10/6/2017)... ... October 06, 2017 , ... The HealthTech Venture Network (HTVN) ... their fourth annual Conference where founders, investors, innovative practitioners and collaborators are invited ... competition showcasing early stage digital health and med tech companies. , This day-long ...
Breaking Biology Technology:
(Date:10/4/2017)...  GCE Solutions, a global clinical research organization (CRO), announces the ... on October 4, 2017. Shadow is designed to assist medical writers ... 0070 of the European Medicines Agency (EMA) in meeting the requirements ... ... ...
(Date:6/23/2017)... ITHACA, N.Y. , June 23, 2017 /PRNewswire/ ... leader in dairy research, today announced a new collaboration ... reduce the chances that the global milk supply is ... dairy project, Cornell University has become the newest academic ... Supply Chain, a food safety initiative that includes IBM ...
(Date:5/6/2017)... 5, 2017 RAM Group , ... new breakthrough in biometric authentication based on a ... properties to perform biometric authentication. These new sensors are ... created by Ram Group and its partners. This sensor ... supply chains and security. Ram Group is a ...
Breaking Biology News(10 mins):